1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Genetic Technologies Limited

Genetic Technologies Limited

GENE
Genetic Technologies LimitedUS flagNASDAQ Capital Market
0.77
USD
- -
- -
111.24MMarket Cap

Total Valuation

Genetic Technologies Limited carries a market capitalization of 111.24M, placing it among publicly traded companies globally. Its enterprise value stands at -145,419.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap111.24M
Enterprise Value-145,419.00

Share Statistics

Genetic Technologies Limited currently has 101.06M shares outstanding.

Shares Outstanding101.06M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Financial Position

Genetic Technologies Limited maintains a current ratio of 0.88, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

Current Ratio0.88
Quick Ratio0.75
Debt / Equity47.81
Debt / EBITDAN/A
Interest CoverageN/A

Stock Price Statistics

Genetic Technologies Limited's stock has declined approximately -75.48077% over the past 52 weeks. The 50-day moving average sits at 0.77, while the 200-day moving average is 1.07.

Beta (5Y)N/A
52-Week Price Change-75.48077%
50-Day Moving Average0.77
200-Day Moving Average1.07
Average Volume (20 Days)N/A

Balance Sheet

Genetic Technologies Limited holds 1.02M in cash and equivalents against 875,189.00 in total debt, resulting in a net debt position of -377,062.00. Total book value stands at -2.56M, with working capital of -500,088.00 providing operational flexibility.

Cash & Cash Equivalents1.02M
Total Debt875,189.00
Net Debt-377,062.00
Equity (Book Value)-2.56M
Book Value Per ShareN/A
Working Capital-500,088.00

Cash Flow

Operating Cash FlowN/A
Capital Expenditures-29,239.00
Free Cash Flow-29,239.00
FCF Per ShareN/A

Stock Splits

Genetic Technologies Limited's most recent stock split took place on December 14, 2023 with a 5:1 split ratio.

Last Split Date12/14/2023
Split Ratio5:1

Scores

Genetic Technologies Limited posts an Altman Z-Score of -57.78, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-57.78